human normal immunoglobulin for intravenous use

Poland

Drugs containing this active substance

  • IG VENA

    The medicinal product is used in adults and children and adolescents for the treatment of antibody deficiencies (replacement therapy) and in the treatment of certain inflammatory diseases, such as immune thrombocytopenia, Guillain–Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN).

    Form: solution for infusion

    Active substance Dosage
    human normal immunoglobulin for intravenous use 50 mg/ml

    ATC: J06BA02

    Manufacturer: Kedrion S.p.A.

  • The medicinal product is used for replacement therapy in individuals with congenital or acquired antibody deficiency and in individuals exposed to measles (in situations where vaccination is contraindicated). It may also be used in the treatment of selected autoimmune disorders, such as immune thrombocytopenia (ITP), Kawasaki disease, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN).

    Form: solution for infusion

    Active substance Dosage
    human normal immunoglobulin for intravenous use 50 mg/ml

    ATC: J06BA02

    Manufacturer: Octapharma Octapharma AB Octapharma GmbH Octapharma Pharmazeutika Produktionsges.m.b.H.

  • The medicine is used to treat bacterial infections (in conjunction with antibiotics) and for replacement therapy in individuals who have insufficient antibodies due to severe immune system deficiencies.

    Form: solution for infusion

    Active substance Dosage
    human normal immunoglobulin for intravenous use 50 mg/ml

    ATC: J06BA02

    Manufacturer: Biotest Pharma GmbH